Bone substitute compositions, methods of preparation and clinical applications
The present invention relates to bone substitute compositions and methods of their preparation, and their use in a wide variety of clinical applications. The compositions include calcium phosphate, acidic calcium salt, basic calcium salt, sodium hydrogen phosphate and porogen. The compositions further include a mixing liquid. The compositions can optionally include biological signaling molecules and/or a growth compound. Further, the compositions can optionally include a plasticizer.
1. A method of repairing or replacing defective native bone tissue, comprising:
preparing a bone substitute composition, comprising:
combining calcium phosphate, acidic calcium salt, basic calcium salt, material selected from the group consisting of monosodium hydrogen phosphate, disodium hydrogen phosphate and mixtures thereof, and porogen to form a powder component; and
mixing the powder component with a liquid colloidal mixture comprising nanoparticulate calcium phosphate and calcium salt;
obtaining a patient having defective native bone tissue; and
administering in vivo the bone substitute composition in a form selected from the group consisting of paste, putty and cement, into the patient at the site of the defective native bone tissue.
2. The method of claim 1 , wherein the repairing or replacing defective native bone tissue is carried out in the absence of a biological growth component.
3. The method of claim 1 , wherein the native bone tissue is in an area selected from the group consisting of orthopedic, dental and craniofacial.
4. The method of claim 1 , wherein the administering of the bone substitute composition is selected from the group consisting of injecting and implanting the bone substitute composition into the patient.
5. The method of claim 1 , wherein surface area of the bone substitute composition is greater than surface area of the powder component.
6. A method for delivering cellular and biological material to a target site in a patient, comprising:
preparing a bone substitute composition, comprising:
combining calcium phosphate, acidic calcium salt, basic calcium salt, material selected from the group consisting of monosodium hydrogen phosphate, disodium hydrogen phosphate and mixtures thereof, and porogen to form a powder component; and
mixing the powder component with a liquid colloidal mixture comprising nanoparticulate calcium phosphate and calcium salt, the colloidal mixture being complexed with at least one of a compound selected from the group consisting of protein, peptide, DNA, drug, stem cell, normal cell, and combinations thereof;
obtaining a patient having defective native bone tissue; and
administering in vivo the bone substitute composition in a form selected from the group consisting of paste, putty and cement, into the patient at the target site.
7. A bone substitute composition, comprising:
a powder component, comprising:
calcium phosphate;
acidic calcium salt;
basic calcium salt;
material selected from the group consisting of monosodium hydrogen phosphate, disodium hydrogen phosphate, and mixtures thereof; and
porogen; and
a liquid component, comprising:
a colloidal mixture comprising nanoparticulate calcium phosphate and calcium salt, the nanoparticulate calcium phosphate formed by reaction of calcium and non-acidic ionic phosphate in the presence of hydroxyl ions,
wherein the composition is effective to regenerate bone in the absence of a biological growth component.
8. The composition of claim 7 , wherein the calcium phosphate is selected from the group consisting of monocalcium monophosphate anhydrite, calcium hydrogenphosphate dihydrate, calcium hydrogenphosphate anhydrite, hydroxyapatite, alpha-tricalcium phosphate, beta-tricalcium phosphate, fluorapatite, octacalcium phosphate , tetracalcium phosphate, carbonated calcium phosphate and mixtures thereof.
9. The composition of claim 8 , wherein the acidic calcium salt is selected from the group consisting of calcium sulfate, calcium hydrogenphosphate dihydrate, calcium hydrogenphosphate anhydrite, calcium oxalate, calcium citrate, calcium tartrate, calcium picrate and mixtures thereof.
10. The composition of claim 8 , wherein the basic calcium salt is selected from the group consisting of calcium carbonate, calcium bicarbonate, calcium dihydroxide, and mixtures thereof.
11. The composition of claim 8 , wherein the porogen is selected from the group consisting of recrystallized organic salt, recrystallized inorganic salt, engineered peptide, natural polymer, a composite of natural and synthetic polymers, synthetic biodegradable polymer, natural extra cellular matrix protein, and mixtures thereof.
12. The composition of claim 8 , wherein the colloidal mixture comprising nanoparticulate calcium phosphate is complexed with at least one of a compound selected from the group consisting of protein, peptide, DNA, drug, stem cell, normal cell, and combinations thereof.
13. The composition of claim 8 , having a porosity of about 80 percent or greater.
14. The composition of claim 8 , wherein calcium ions are present in excess in the reaction as compared to phosphate ions.
15. A bone substitute composition, comprising:
a powder component, comprising:
calcium phosphate;
acidic calcium salt;
basic calcium salt;
material selected from the group consisting of monosodium hydrogen phosphate, disodium hydrogen phosphate, and mixtures thereof; and
porogen; and
a liquid component, comprising:
a colloidal mixture comprising nanoparticulate calcium phosphate and calcium salt, the nanoparticulate calcium phosphate formed by reaction of calcium and non-acidic ionic phosphate in the presence of hydroxyl ions,
wherein the porogen is present in an amount such that the composition has a porosity of about 80% or greater.
16. The composition of claim 15 , wherein the composition has a surface area from about 60 m 2 /g to about 120 m 2 /g.